Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Monopar Therapeutics Inc (NQ: MNPR ) 2.430 -0.010 (-0.41%) Streaming Delayed Price Updated: 3:58 PM EDT, Sep 5, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Monopar Therapeutics Inc < Previous 1 2 3 4 5 6 Next > Monopar to Participate in the H.C. Wainwright 26th Annual Global Investment Conference September 04, 2024 From Monopar Therapeutics Inc. Via GlobeNewswire Monopar Regains Compliance with Nasdaq Minimum Bid Price Rule August 27, 2024 From Monopar Therapeutics Inc. Via GlobeNewswire Monopar Receives Clearance to Proceed with Phase 1 Therapeutic Trial of Novel Radiopharmaceutical in Advanced Cancers August 21, 2024 From Monopar Therapeutics Inc. Via GlobeNewswire Recap: Monopar Therapeutics Q4 Earnings March 28, 2024 Via Benzinga Monopar Announces Initial Data for First Patient Dosed in Radiopharma Phase 1 Clinical Trial of MNPR-101-Zr August 14, 2024 From Monopar Therapeutics Inc. Via GlobeNewswire MNPR Stock Earnings: Monopar Therapeutics Misses EPS for Q2 2024 August 09, 2024 MNPR stock results show that Monopar Therapeutics missed analyst estimates for earnings per share the second quarter of 2024. Via InvestorPlace Monopar Therapeutics Reports Second Quarter 2024 Financial Results and Recent Developments August 09, 2024 From Monopar Therapeutics Inc. Via GlobeNewswire Monopar Therapeutics Announces 1-for-5 Reverse Stock Split August 09, 2024 From Monopar Therapeutics Inc. Via GlobeNewswire Monopar Announces First Patient Enrolled in First-in-Human Phase 1 Trial for Its Novel Radiopharmaceutical MNPR-101-Zr July 09, 2024 From Monopar Therapeutics Inc. Via GlobeNewswire Monopar Announces MNPR-101-RIT Abstract Accepted as a Top-Rated Oral Presentation at EANM’24 June 25, 2024 From Monopar Therapeutics Inc. Via GlobeNewswire Monopar Therapeutics And 2 Other Stocks Under $2 Insiders Are Buying June 24, 2024 Via Benzinga Monopar and NorthStar Amend & Extend Collaboration June 11, 2024 From Monopar Therapeutics Inc. Via GlobeNewswire Monopar Presents Data Showcasing the Appeal of uPAR as a Radiopharma Cancer Target and of its lead Clinical Program at the 2024 SNMMI Annual Meeting June 10, 2024 From Monopar Therapeutics Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Friday's Pre-Market Session June 07, 2024 Via Benzinga Penny Stocks That Insiders Are Loading Up On: 3 Names to Watch Closely June 05, 2024 Penny stocks are risky. It’s why we attach a warning to the tail-end of penny stock articles and why the SEC has a warning about them too. Via InvestorPlace Topics Regulatory Compliance Exposures Legal Regulatory Monopar Therapeutics And 2 Other Stocks Under $2 Insiders Are Buying June 03, 2024 Via Benzinga Monopar Announces CFO Succession May 24, 2024 From Monopar Therapeutics Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Thursday's After-Market Session May 09, 2024 Via Benzinga MNPR Stock Earnings: Monopar Therapeutics Beats EPS for Q1 2024 May 09, 2024 MNPR stock results show that Monopar Therapeutics beat analyst estimates for earnings per share the first quarter of 2024. Via InvestorPlace Monopar Therapeutics Reports First Quarter 2024 Financial Results and Strategic Focus on its Radiopharma Pipeline May 09, 2024 From Monopar Therapeutics Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Friday's After-Market Session May 03, 2024 Via Benzinga Monopar Announces Radiopharma Presentation Selected for Society of Nuclear Medicine and Molecular Imaging 2024 Annual Meeting April 18, 2024 From Monopar Therapeutics Inc. Via GlobeNewswire Monopar Announces Filing of Patent Protecting MNPR-101 Radiopharma Optimization Findings April 16, 2024 From Monopar Therapeutics Inc. Via GlobeNewswire Monopar Initiates Radiopharma Phase 1 Clinical Trial for MNPR-101-Zr in Advanced Cancer Patients April 10, 2024 From Monopar Therapeutics Inc. Via GlobeNewswire MNPR Stock Earnings: Monopar Therapeutics Beats EPS for Q4 2023 March 28, 2024 MNPR stock results show that Monopar Therapeutics beat analyst estimates for earnings per share the fourth quarter of 2023. Via InvestorPlace Monopar Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Developments March 28, 2024 From Monopar Therapeutics Inc. Via GlobeNewswire Monopar Announces Positive Preclinical Therapeutic Isotope Data for its MNPR-101 Radiopharma Program March 05, 2024 From Monopar Therapeutics Inc. Via GlobeNewswire Why Peraso Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session March 19, 2024 Shares of Peraso Inc. (NASDAQ: PRSO) fell sharply during Tuesday’s session after the company reported worse-than-expected fourth-quarter EPS results. Via Benzinga Monopar Provides Update on MNPR-101-Zr Radiopharma Clinical Trial February 27, 2024 From Monopar Therapeutics Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Monday's Pre-Market Session February 26, 2024 Via Benzinga < Previous 1 2 3 4 5 6 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.